000 01201 a2200337 4500
005 20250515064217.0
264 0 _c20080118
008 200801s 0 0 eng d
022 _a1863-4362
024 7 _a10.1007/s11845-007-0026-x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLangabeer, S E
245 0 0 _aIncidence and significance of the JAK2 V617F mutation in patients with chronic myeloproliferative disorders.
_h[electronic resource]
260 _bIrish journal of medical science
_c
300 _a105-9 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aChronic Disease
650 0 4 _aHumans
650 0 4 _aJanus Kinase 2
_xgenetics
650 0 4 _aMutation
650 0 4 _aMyeloproliferative Disorders
_xgenetics
650 0 4 _aPolycythemia Vera
_xgenetics
650 0 4 _aPolymerase Chain Reaction
650 0 4 _aPrimary Myelofibrosis
_xgenetics
650 0 4 _aThrombocythemia, Essential
_xgenetics
700 1 _aNi Ainle, F
700 1 _aConneally, E
700 1 _aLawler, M
773 0 _tIrish journal of medical science
_gvol. 176
_gno. 2
_gp. 105-9
856 4 0 _uhttps://doi.org/10.1007/s11845-007-0026-x
_zAvailable from publisher's website
999 _c16990843
_d16990843